Related Experiment Video
Updated: Nov 17, 2025

Assessing Activity-based Anorexia in Mice
Published on: May 14, 2018
Dopaminergic activity and exercise behavior in anorexia nervosa
Sasha Gorrell1, Anne G E Collins2, Daniel Le Grange1,3
1Department of Psychiatry, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Driven exercise in anorexia nervosa (AN) is poorly understood but linked to poorer outcomes. Dopamine signaling may play a key role in this compulsive behavior, offering new avenues for treatment research.
Area of Science:
- Neuroscience
- Psychiatry
- Behavioral Science
Background:
- Driven exercise is a common, poorly understood symptom in anorexia nervosa (AN).
- This behavior negatively impacts treatment outcomes and is linked to psychological and medical severity.
- Dopamine signaling is known to influence motivated behaviors in eating disorders, but its specific role in AN-related driven exercise is unclear.
Purpose of the Study:
- To review the role of dopamine signaling in maintaining driven exercise in anorexia nervosa.
- To synthesize current evidence on exercise behaviors and dopaminergic activity in AN.
- To discuss theoretical implications and identify future research directions.
Main Methods:
- Literature review synthesizing existing research on driven exercise in AN.
- Analysis of studies investigating dopaminergic activity in relation to exercise in AN.
- Discussion of theoretical frameworks and research gaps.
Main Results:
- Dopamine signaling is implicated in motivated behaviors relevant to eating disorders.
- Evidence suggests a potential role for dopamine in the maintenance of driven exercise in AN.
- Further research is needed to fully elucidate this biobehavioral mechanism.
Conclusions:
- Understanding dopamine's role in driven exercise is crucial for improving AN treatment.
- This review highlights the need for targeted research into the neurobiology of driven exercise in AN.
- Identifying dopaminergic mechanisms could lead to novel therapeutic strategies for AN.
More Related Videos
07:46Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa
Published on: October 22, 2015
10:19Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease
Published on: August 22, 2014
Related Concept Videos
Anorexia Nervosa
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Bulimia Nervosa
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...